Monarch Medical Technologies & Voluntis to Host Webinar on Use of Technology to Support Inpatient & Outpatient Insulin Manage...
17 Juin 2019 - 4:21PM
Business Wire
The June 25th Webinar to Discuss Best Practices
for Initiating and Managing Insulin Therapy Across the Continuum of
Care.
Despite advances in treatment and clear guidelines, many
patients with diabetes are failing to achieve target glucose levels
both in the inpatient and outpatient setting. One of the main
challenges posing a barrier is clinical inertia preventing the
initiation and intensification of insulin therapy. Insulin therapy
has been proven to significantly reduce hemoglobin A1c levels in
individuals with diabetes and better manage hyperglycemia, yet
countless studies show that insulin initiation and intensification
is frequently and inappropriately delayed.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190617005540/en/
Monarch and Voluntis, who formed a business relationship last
year, are partnering to offer a complimentary webinar, “How
Technology Can Support Adoption of Best Practices for Inpatient and
Outpatient Insulin Management.” The webinar will discuss the
current challenges in initiating and managing insulin therapy,
review the recommended practices in both the inpatient and
outpatient setting, and discuss how technology can be used and
implemented to benefit both patients and providers.
You may register for the webinar here.
When
Tuesday, June 25, 2019 at 12:00 pm EST
Speakers
Amy Butts PA-C, MPAS, CDE, BC-ADM, Endocrine Physician
Assistant, Wheeling Hospital
Mark Vanderwel, MD, Medical Director of the Pediatric
Endocrinology Division, Atrium Health
Learning Objectives
- Discuss the difficulties that providers
and patients have with managing insulin dosing
- Review the 2019 ADA Standards of
Medical Care in Diabetes for insulin management
- Provide examples of how technology can
support inpatient and outpatient insulin titration
- Describe strategies to integrate
technology into your environment
Following the live webinar, a recording will be available to
download on monarchmedtech.com within 24 hours of the live
event.
About Monarch Medical Technologies
Monarch Medical Technologies is the leading provider of
electronic systems for inpatient glycemic management. Monarch’s
EndoTool® Glucose Management System offers personalized dosing
recommendations for intravenous and subcutaneous insulin therapy.
As a Class II FDA-cleared, patented software suite, EndoTool has
been chosen by more than 300 hospitals to provide unsurpassed
patient-specific glycemic control across a broad population of
patients, and ultimately deliver better, safer care. For more
information, please visit monarchmedtech.com.
About Voluntis
Voluntis creates digital therapeutics that empower people
suffering from chronic conditions to self- manage their treatment
every day, thus improving real-world outcomes. Combining mobile and
web apps, Voluntis’ solutions deliver personalized recommendations
to the patient and the care team so that they can, for example,
adjust treatment dosage, manage side effects or monitor symptoms.
These real- time recommendations are based on digitized clinical
algorithms. Leveraging its Theraxium technology platform, Voluntis
has designed and operates multiple digital therapeutics, especially
in diabetes and oncology. Voluntis has long-standing partnerships
with leading life science companies such as Abbvie, AstraZeneca,
Roche, Sanofi and Onduo. Based out of Boston and Paris, France,
Voluntis is a founding member of the Digital Therapeutics Alliance.
For further information: http://www.voluntis.com.Voluntis is traded
on the Euronext Paris – Compartment C marketTicker: VTX – ISIN:
FR0004183960
Diabeo® is a registered trademark of Sanofi. Insulia® is a
registered trademark of Voluntis.
For further information: http://www.voluntis.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190617005540/en/
Flannery NangleMonarch Medical
Technologies315-406-5495flannery.nangle@monarchmedtech.comAlexandre
CapetVoluntis+33141387433press@voluntis.com